Gemfibrozil 600 MG Oral Tablet — RxCUI 310459
RxNorm drug concept · Semantic clinical drug
RxCUI 310459
Semantic clinical drug · SCD
● Current RxNorm concept 43 FDA products
123 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI310459
Official nameGemfibrozil 600 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped43
Package NDCs mapped123
Reported Medicaid activity (SDUD)236,607 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Gemfibrozil: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on why your doctor prescribed it. For most people, it's either bringing down dangerously high triglycerides — the type that can cause pancreatitis — or, in a specific gr...
- What exactly is gemfibrozil supposed to do for me?
- Yes, timing actually matters with this one. You take it twice a day — once about 30 minutes before breakfast and once about 30 minutes before your evening meal. Taking it before yo...
- When should I take it and does it matter if I take it with food?
🕸️ Concept Web — How Gemfibrozil 600 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Gemfibrozil 600 MG Oral Tablet
RxCUI 310459 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Gemfibrozil
4719IN
-
Gemfibrozil
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lopid
202999BN
-
Lopid
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Gemfibrozil Oral Tablet
372300SCDF -
Gemfibrozil Oral Product
1163944SCDG -
Gemfibrozil Pill
1163945SCDG -
Gemfibrozil Oral Tablet [Lopid]
369510SBDF -
Lopid Oral Product
1179662SBDG -
Lopid Pill
1179663SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Gemfibrozil Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Gemfibrozil 600 MG
317636SCDC -
Gemfibrozil 600 MG Oral Tablet [Lopid]
205751SBD -
Gemfibrozil 600 MG [Lopid]
566639SBDC
-
Gemfibrozil 600 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Gemfibrozil 600 MG
SCDC · 317636 -
Gemfibrozil Oral Tablet
SCDF · 372300 -
Gemfibrozil Oral Product
SCDG · 1163944 -
Gemfibrozil Pill
SCDG · 1163945
Brand-Name Concepts
-
Gemfibrozil 600 MG Oral Tablet [Lopid]
SBD · 205751 -
Gemfibrozil 600 MG [Lopid]
SBDC · 566639 -
Gemfibrozil Oral Tablet [Lopid]
SBDF · 369510 -
Lopid Oral Product
SBDG · 1179662 -
Lopid Pill
SBDG · 1179663 -
Lopid
BN · 202999
📦 FDA Products & Package NDCs
43 products · 123 package NDCs
123 package NDCs map to RxCUI 310459 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00071-0737-20 | 60 TABLET, FILM COATED in 1 BOTTLE (0071-0737-20) | Lopid | Parke-Davis Div of Pfizer Inc | 2004-03-30 |
| 00071-0737-30 | 500 TABLET, FILM COATED in 1 BOTTLE (0071-0737-30) | Lopid | Parke-Davis Div of Pfizer Inc | 2004-03-30 |
| 00615-8354-39 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8354-39) | Gemfibrozil | NCS HealthCare of KY, LLC dba Vangard Labs | 2020-11-10 |
| 16571-0784-06 | 60 TABLET, FILM COATED in 1 BOTTLE (16571-784-06) | Gemfibrozil | Rising Pharma Holdings, Inc. | 2015-09-16 |
| 16571-0784-50 | 500 TABLET, FILM COATED in 1 BOTTLE (16571-784-50) | Gemfibrozil | Rising Pharma Holdings, Inc. | 2015-09-16 |
| 16714-0101-02 | 60 TABLET in 1 BOTTLE (16714-101-02) | Gemfibrozil | Northstar RxLLC | 2010-12-20 |
| 16714-0101-05 | 500 TABLET in 1 BOTTLE (16714-101-05) | Gemfibrozil | Northstar RxLLC | 2010-12-20 |
| 31722-0128-05 | 500 TABLET in 1 BOTTLE (31722-128-05) | GEMFIBROZIL | Camber Pharmaceuticals, Inc. | 2021-01-20 |
| 31722-0128-60 | 60 TABLET in 1 BOTTLE (31722-128-60) | GEMFIBROZIL | Camber Pharmaceuticals, Inc. | 2021-01-20 |
| 43063-0745-60 | 60 TABLET in 1 BOTTLE, PLASTIC (43063-745-60) | Gemfibrozil | PD-Rx Pharmaceuticals, Inc. | 2017-02-09 |
| 43063-0745-93 | 180 TABLET in 1 BOTTLE, PLASTIC (43063-745-93) | Gemfibrozil | PD-Rx Pharmaceuticals, Inc. | 2017-12-12 |
| 50090-5808-00 | 60 TABLET in 1 BOTTLE (50090-5808-0) | GEMFIBROZIL | A-S Medication Solutions | 2021-10-15 |
| 50090-5808-02 | 90 TABLET in 1 BOTTLE (50090-5808-2) | GEMFIBROZIL | A-S Medication Solutions | 2021-10-15 |
| 50090-5808-03 | 30 TABLET in 1 BOTTLE (50090-5808-3) | GEMFIBROZIL | A-S Medication Solutions | 2021-10-15 |
| 50090-5808-04 | 180 TABLET in 1 BOTTLE (50090-5808-4) | GEMFIBROZIL | A-S Medication Solutions | 2021-10-15 |
| 50090-6913-00 | 60 TABLET in 1 BOTTLE (50090-6913-0) | Gemfibrozil | A-S Medication Solutions | 2023-12-12 |
| 50090-6913-02 | 90 TABLET in 1 BOTTLE (50090-6913-2) | Gemfibrozil | A-S Medication Solutions | 2023-12-12 |
| 50090-6913-03 | 30 TABLET in 1 BOTTLE (50090-6913-3) | Gemfibrozil | A-S Medication Solutions | 2023-12-12 |
| 50090-6913-04 | 180 TABLET in 1 BOTTLE (50090-6913-4) | Gemfibrozil | A-S Medication Solutions | 2023-12-12 |
| 50090-6939-00 | 90 TABLET in 1 BOTTLE (50090-6939-0) | Gemfibrozil | A-S Medication Solutions | 2023-12-15 |
| 50090-7233-00 | 60 TABLET, FILM COATED in 1 BOTTLE (50090-7233-0) | Gemfibrozil | A-S Medication Solutions | 2024-08-26 |
| 50090-7233-02 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-7233-2) | Gemfibrozil | A-S Medication Solutions | 2024-08-26 |
| 50090-7233-03 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-7233-3) | Gemfibrozil | A-S Medication Solutions | 2024-08-26 |
| 50090-7233-04 | 180 TABLET, FILM COATED in 1 BOTTLE (50090-7233-4) | Gemfibrozil | A-S Medication Solutions | 2024-08-26 |
| 50090-7234-00 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-7234-0) | Gemfibrozil | A-S Medication Solutions | 2024-08-26 |
| 50090-7809-00 | 90 TABLET in 1 BOTTLE (50090-7809-0) | GEMFIBROZIL | A-S Medication Solutions | 2025-12-04 |
| 50268-0350-15 | 50 BLISTER PACK in 1 BOX (50268-350-15) / 1 TABLET in 1 BLI... | Gemfibrozil | AvPAK | 2014-07-10 |
| 51655-0143-25 | 60 TABLET in 1 BOTTLE, PLASTIC (51655-143-25) | Gemfibrozil | Northwind Health Company, LLC | 2022-12-06 |
| 51655-0143-26 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-143-26) | Gemfibrozil | Northwind Health Company, LLC | 2017-08-14 |
| 51655-0143-52 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-143-52) | Gemfibrozil | Northwind Health Company, LLC | 2017-11-13 |
| 51655-0143-83 | 180 TABLET in 1 BOTTLE, PLASTIC (51655-143-83) | Gemfibrozil | Northwind Health Company, LLC | 2017-08-14 |
| 60687-0224-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-224-01) / 1 TAB... | Gemfibrozil | American Health Packaging | 2016-07-07 |
| 62135-0160-31 | 300 TABLET, FILM COATED in 1 BOTTLE (62135-160-31) | Gemfibrozil | Chartwell RX, LLC | 2023-08-25 |
| 62135-0160-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62135-160-60) | Gemfibrozil | Chartwell RX, LLC | 2023-08-25 |
| 63187-0772-30 | 30 TABLET in 1 BOTTLE (63187-772-30) | Gemfibrozil | Proficient Rx LP | 2016-11-01 |
| 63187-0772-60 | 60 TABLET in 1 BOTTLE (63187-772-60) | Gemfibrozil | Proficient Rx LP | 2016-11-01 |
| 63187-0772-72 | 120 TABLET in 1 BOTTLE (63187-772-72) | Gemfibrozil | Proficient Rx LP | 2016-11-01 |
| 63187-0772-78 | 180 TABLET in 1 BOTTLE (63187-772-78) | Gemfibrozil | Proficient Rx LP | 2016-11-01 |
| 63187-0772-90 | 90 TABLET in 1 BOTTLE (63187-772-90) | Gemfibrozil | Proficient Rx LP | 2016-11-01 |
| 65862-0624-05 | 500 TABLET, FILM COATED in 1 BOTTLE (65862-624-05) | Gemfibrozil | Aurobindo Pharma Limited | 2015-09-16 |
| 65862-0624-60 | 60 TABLET, FILM COATED in 1 BOTTLE (65862-624-60) | Gemfibrozil | Aurobindo Pharma Limited | 2015-09-16 |
| 66267-0436-30 | 30 TABLET in 1 BOTTLE (66267-436-30) | Gemfibrozil | NuCare Pharmaceuticals, Inc. | 2016-11-15 |
| 66267-0436-60 | 60 TABLET in 1 BOTTLE (66267-436-60) | Gemfibrozil | NuCare Pharmaceuticals, Inc. | 2016-11-15 |
| 66267-0436-92 | 180 TABLET in 1 BOTTLE (66267-436-92) | Gemfibrozil | NuCare Pharmaceuticals, Inc. | 2016-11-15 |
| 67046-0233-03 | 30 TABLET in 1 BLISTER PACK (67046-0233-3) | Gemfibrozil | Coupler LLC | 2026-04-29 |
| 68071-1733-06 | 60 TABLET in 1 BOTTLE (68071-1733-6) | Gemfibrozil | NuCare Pharmaceuticals,Inc. | 2017-09-14 |
| 68071-2387-03 | 30 TABLET in 1 BOTTLE (68071-2387-3) | GEMFIBROZIL | NuCare Pharmaceuticals,Inc. | 2021-04-13 |
| 68071-2387-06 | 60 TABLET in 1 BOTTLE (68071-2387-6) | GEMFIBROZIL | NuCare Pharmaceuticals,Inc. | 2021-04-13 |
| 68071-2387-08 | 180 TABLET in 1 BOTTLE (68071-2387-8) | GEMFIBROZIL | NuCare Pharmaceuticals,Inc. | 2021-04-13 |
| 68382-0553-01 | 100 TABLET in 1 BOTTLE (68382-553-01) | Gemfibrozil | Zydus Pharmaceuticals (USA) Inc. | 2019-01-15 |
Observed labelers:
Bryant Ranch Prepack (21) ·
A-S Medication Solutions (15) ·
Aphena Pharma Solutions - Tennessee, LLC (10) ·
Viona Pharmaceuticals Inc (7) ·
Zydus Lifesciences Limited (7) ·
Zydus Pharmaceuticals (USA) Inc. (7)
· +23 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.